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Abstract: The aim of the present study was
to investigate the role of the L-type voltage
dependent Ca2+ channel blocker, nimodipine,
in kainate induced toxicity in retinal ganglion
cells of mice. Kainate in 10mg/kg was
administered intraperitoneally following the
vehicle or nimodipine. Nimodipine, 45
minutes prior to kainate in 10, 15, 25, 50,
100 and 250 mg/kg doses was administered
intraperitoneally. Surprisingly, nimodipine
potentiated the ganglional cell death induced
by kainate, with respect to the control and
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Introduction
The uncontrolled release of neurotransmitters has
been suggested to play a major role in mediating ischemic
damage in susceptible brain regions (1). Most studies
have emphasized the detrimental role of excessive release
of the excitatory amino acid, glutamate, in producing
ischemic injury (2). The main glutamate receptor involved
in the cytotoxic process is the receptor sensitive to Nmethyl-D-aspartate (NMDA) which is permeable to Na+
and Ca2+(3). However, another ionotropic receptor, the αamino-3 hydroxy-5-methyl-4-isoxasole propionate/
kainate (AMPA/KA) receptor, particularly distributed on
retinal neurons, can also be involved in ischemic neuronal
degeneration (4). In the retina, photoreceptors and
bipolar neurons are immunoreactive for glutamate (5). In
the retina, seven genes encoding functional subunits of
AMPA/KA type glutamate receptors have been identified
using in situ hybridization, suggesting the possible
presence of Ca2+-permeable AMPA/KA receptors in this
tissue (6). Using the patch-clamp technique, the presence
of calcium permeable non-NMDA Na+/Ca2+ channels in
retinal neurons was demonstrated (7). Na+ influx can be
involved in the toxic process by leading to osmotic stress
(8) but also, via depolarization, by opening voltage

kainate+vehicle treated group. In accordance
with our results, blockage of L-type calcium
channels by nimodipine may worsen the
prognosis and survival of retinal neurons in
kainate receptor stimulated toxicity. Blocking
of calcium channels may lead to the rebound
activation of sodium channels or stimulate
the release of intracellular calcium by
activating ryanodine sensitive calcium
channels.
Key Words: Kainate, retina, nimodipine,
neurotoxicity, mice.

operated calcium channels. Ca2+ influx can damage
neurons by activating various enzymes such as xanthine
oxidase and nitric oxide synthetase (9) that was shown to
play an important role in excitatory amino acid-induced
neuronal injury by generating oxygen derived free
radicals. On the other hand, calcium channel blockers
were reported to undergo selective neuronal degradation
in cerebral cortical cultures of rats in a concentration
dependent fashion (10) and this was attenuated by
protein synthesis inhibitors. This result has been
explained by the fact that a decrease in intraneuronal
calcium levels may lead to synthesis of proteins mediating
neuronal cell death.
Methods
Albino mice weighing 28-36 g, were used. Mice were
housed at 23-25 °C and 60% humidity with a 12/12
hour light/dark (light on 06:00, off at 18:00) cycle. Mice
were given rat chow and tap water ad libitum. Each
experimental group consisted of eight mice. In accordance
with a previous study (11), the most toxic systemic
concentration of KA of 10 µg/kg was administered
intraperitoneally following the vehicle or nimodipine.
Nimodipine, 45 minutes prior to KA in 10, 15, 25, 50,
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100 and 250 µg/kg doses was used intraperitoneally.
Animals were allowed to survive for an additional 48
hours after the last injection. The mice were sacrificed by
decapitation and the eyes were removed immediately and
stored in 10% buffered formaldehyde for 72 hours,
horizontal sections passing through the plate of optic
nerve were taken, embedded in parafin, and cut in 4µmthick sections. Following this procedure, the eyes were
stained with hematoxylin-eosin. Slide labels were covered
with tape to enable blind evaluation. Under light
microscopic examination, ganglion cells were counted in
the ganglion cell layer in 3 high-power (10x40
magnification) fields. For each preparation, three areas
were examined. Average number of intact ganglion cells
per preparation was calculated.

nimodipine induced cell death in systemic KA toxicity in
ganglion cells of the retina with respect to the control and
KA+vehicle treated group. Intact cell scores were
60.0±1.57 for 10 µg/kg, 58.28±1.85 for 15 µg/kg,
55.58±1.94 for 25 µg/kg, 55.39±3.21 for 50 µg/kg,
69.28±1.66 for 100 µg/kg and 50.58±1.44 for 250
mg/kg nimodipine plus 10 µg/kg KA injected groups. All
the scores presented above were highly statistically
significant with respect to the control (p<0.0001 for all)
and with respect to the 10 µg/kg KA+vehicle
administered group (p<0.0005 for 100 µg/kg
nimodipine+KA, p<0.0001 for others). The data are
shown in figure 1. Microscopic photographs of intact and
degenerated retinal ganglional cells are presented in
figure 2 a-b-c.

The scores were analyzed statistically with the
Kolmogorov-Smirnov test with p<0.05 required for
significance.

Discussion

Results
Mean±SEM scores of intact cells were 94.63±3.36
for the control and 82.33±3.12 for 10 mg/kg KAadministered group (Z:1.44 p:0.031). Surprisingly,

Since the importance of the involvement of
extracellular Ca+2 in the neurodegenerative process
induced by excitatory amino acids in ischemia was unclear,
to detect the neuroprotective effect of Ca+2 channel
blockers, some important studies were carried out and
some Ca+2 antagonists were reported to prevent the
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Intact neuronal cell population mean scores per area in 10x40 magnification in kainate and nimodipine or vehicle administered mice. Con:
Control, KA: Kainate (10 mg/kg intraperitoneally), Veh: Vehicle, Nim: Nimodipine (µM), *p<0.05 **p<0.0001 with respect to control,
≠p<0.0005, ≠≠p<0.0001 (n=7 for each group).
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Figure 2.

Photomicrographs show
control group (a), slight
retinal ischemic damage
belongs to 100 nM
Nim+KA group(b) and
severe ischemic damage
belongs to 250 nM
Nim+KA group (c) ,
(10X40).
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neuronal damage of ischemia in vivo (12). In general, in
vitro experiments revealed only a slight effect of these
drugs (13).
Our present paper demonstrates that as a Ca+2
channel blocker, nimodipine, had no neuroprotective
effect and even worsened KA-induced ganglional cell
death in mice retina. In the literature, a few studies
described the neuroprotective effects of calcium channel
blockers in retinal ischemia (14, 15). In primary culture
of rat cerebellar granule cells, Pizzi and co-workers found
that nifedipine used at 100 nM concentration,
significantly counteracted the neuronal death induced by
15 minute application of 50 µM glutamate (16) Zhang
and co-workers also showed that nifedipine had less
effect on reducing the rise in intracellular Ca+2 level that
causes neuronal death (17).
The efficacy of different Ca+2 entry blockers was
evaluated in preventing the neurodegenerative effects
induced by stimulation of distinct glutamate receptor
subtypes so far and it was evaluated that different Ca+2
antagonists produced different pharmacological
potentiation on blockage of voltage operated channels
and receptor operated channels in the central system
(17). These differences may be due to the different
binding affinities and concentrations of these antagonists.
It is quite clear that the calcium channel blockers do not
show equal activity towards all calcium channels and some
major differences in selectivity occur between tissues and
also it is possible that selectivity of antagonism may occur
between different vascular beds (18). In retinal cells, Ca+2
influx is induced through AMPA/KA receptor stimulation

(19), however intracellular Ca+2 is also subsequently
mobilized through a Ca+2 induced Ca+2 release in KA
induced retinal neurons (3). The using patch-clamp
technique, the presence of non-NMDA Na+/Ca+2 channels
in retinal neurons was also demonstrated (7). On the
other hand, the involvement of Na+ influx in excitatory
amino acid induced toxicity was reported (8).
Koh and Cotman reported that cerebral cortical
cultures exposed for 2 days to different Ca+2 channel
blockers undergo selective neuronal degeneration in a
concentration dependent fashion and this degeneration
could be attenuated by protein synthesis inhibitors. It was
suggested in their studies that a decrease in intraneuronal
calcium levels using Ca+2 channel blockers may trigger
synthesis of proteins mediating neuronal cell death (10 ).
In accordance with our results, blockage of L-type
calcium channels by nimodipine may worsen the
prognosis and survival of retinal neurons in KA receptor
stimulated toxicity. Since there is now evidence for a
bidirectional Na+ - Ca+2 exchange system that mediates
movement of Ca+2 across the sarcolemma, blocking of
calcium channels may lead to the rebound activation of
sodium channels or stimulate the release of intracellular
calcium from stores by activating ryanodine sensitive
calcium channels (20).
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